Abrinica, Clyde .

HRN: 27-22-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2025
CIPROFLOXACIN 500MG (TAB)
11/03/2025
11/10/2025
NGT
80mg/pptab
Q12
Pseudomonas Aeroginosa Infection
Checking Final Appropriateness 

Indication:  Culture-directed    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: